Chris Nave

Chris Nave is currently Chief Executive Officer at Medical Research Commercialisation Fund Trust.
Current roles also include Chairman at PolyActiva Pty Ltd. and OccuRx Pty Ltd, Director & Member at Australian Investment Council Ltd., Founding Partner & Managing Director at Brandon Capital Partners Pty Ltd., Non-Executive Director at Osprey Medical, Inc. and EBR Systems, Inc., and Director at Global Kinetics Pty Ltd., BACE Therapeutics Pty Ltd., QUE Oncology, Inc., Azura Ophthalmics Ltd., Cardiora Pty Ltd., Certa Therapeutics Pty Ltd., and Pathios Therapeutics Ltd. Memberships include BioMelbourne Network and AusBiotech Ltd. Former positions include Director-Commercialization at Alfred Health, Director at Hatchtech Pty Ltd., Spinifex Pharmaceuticals Pty Ltd., Fibrotech Therapeutics Pty Ltd., and Athena Medicines Pty Ltd., Commercialization Director at Baker Heart & Diabetes Institute, Non-Executive Director at Otifex Therapeutics Pty Ltd., and Manager at Melbourne Ventures Pty Ltd. Education includes undergraduate and doctorate degrees from the University of Melbourne.